InvestorsHub Logo
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Re: AVII77 post# 104239

Friday, 02/24/2017 11:19:14 AM

Friday, February 24, 2017 11:19:14 AM

Post# of 705299
Oh, tell me what was his progression event then that was given? Answer: he did not record a progression event and UCLA used MacDonald criteria.

Incidentally he never progressed, but you like to insist that his scan would qualify as progression. Meanwhile if you were correct than this study would have reached PFS a long time ago. You finally admit this morning you were wrong about that. But at the same time refuse to admit that also means you were wrong with how progression under MacDonald is confirmed. They used MacDonald criteria in Phase I/II, the same way as Brandes did. It is like I stated Brad did not have a progression event, as progression is NEVER confirmed on the basis of the first MRI after which is the Post RT MRI. And neither did the Indeterminate patients who remain alive have a progression event. Linda Liau stated they are without a progression event and so therefore it should be clear to you that they are outliving RT/TMZ standard of care. It is not the norm to go over 3 years, let alone >5 years without a progression event, even for psPDs and yet that is exactly what is the case for the Indeterminate patients. Just like Brad, they are Without a progression event. Listen to her speech again, you apparently have been too busy focused at reclassifying Scans with your eyeballs because you're clueless about what qualifies as progression free survival and what doesn't. Hint, psPD scans on Post RT MRI do not constitute progression under any criterium.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News